Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A hapten-specific chimaeric IgE antibody with human physiological effector function.

M S Neuberger, G T Williams, E B Mitchell

    Nature
    |March 21, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Lipidomic Analysis Reveals Drug-Induced Lipoxins in Glaucoma Treatment.

    bioRxiv : the preprint server for biology·2025
    Same author

    Correction: Functional redundancy between Apc and Apc2 regulates tissue homeostasis and prevents tumorigenesis in murine mammary epithelium.

    Oncogene·2024
    Same author

    Side-grooved Charpy impact testing: Assessment of splitting and fracture properties of high-toughness plate steels.

    Materials science & engineering. A, Structural materials : properties, microstructure and processing·2023
    Same author

    Whole-genome-scale identification of novel non-protein-coding RNAs controlling cell proliferation and survival through a functional forward genetics strategy.

    Scientific reports·2022
    Same author

    Identification and Sequencing of Bcl and Apaf1 Genes in the Common Carp, Cyprinus Carpio.

    TheScientificWorldJournal·2018
    Same author

    Aqueous humor endothelin-1 and total retinal blood flow in patients with non-proliferative diabetic retinopathy.

    Eye (London, England)·2017
    Same journal

    Daily briefing: 'Cyborg' cockroaches breathe underwater with printed suit.

    Nature·2026
    Same journal

    China boosts prestigious grants for young scientists - will it ease competition?

    Nature·2026
    Same journal

    Incoming US science academy chief vows to 'double down' on research.

    Nature·2026
    Same journal

    Author Correction: Synthesis of enantioenriched atropisomers by biocatalytic deracemization.

    Nature·2026
    Same journal

    Electrodeposited self-assembled molecules for perovskite photovoltaics.

    Nature·2026
    Same journal

    Neutrino's nursery found: the 'Shadow Blaster'.

    Nature·2026
    See all related articles

    Researchers created a novel chimeric immunoglobulin E (IgE) antibody. This engineered IgE can trigger allergic reactions or block them, offering new therapeutic possibilities for allergies.

    Area of Science:

    • Immunology
    • Allergy research

    Background:

    • Immunoglobulin E (IgE) plays a key role in allergic reactions.
    • IgE binds to mast cells and basophils, leading to mediator release upon allergen crosslinking.
    • Existing methods using myeloma IgE for blocking are limited by supply.

    Purpose of the Study:

    • To construct a mouse cell line secreting a chimeric IgE antibody.
    • To investigate the functional properties of this engineered IgE in allergic responses.

    Main Methods:

    • Gene engineering techniques were used to create a chimeric IgE with a human C epsilon constant region and a mouse variable (VH) region.
    • The chimeric IgE was tested for its ability to bind to the hapten 4-hydroxy-3-nitro-phenacetyl (NP).
    • The capacity of the chimeric IgE to trigger human basophil degranulation and block passive sensitization was evaluated.

    Related Experiment Videos

    Main Results:

    • A mouse cell line successfully secreted a chimeric IgE specific for the NP hapten.
    • Crosslinked chimeric IgE triggered human basophil degranulation.
    • Uncrosslinked chimeric IgE inhibited passive sensitization of basophils by allergic sera.

    Conclusions:

    • The engineered chimeric IgE antibody demonstrates dual functionality in allergic responses.
    • This novel IgE has potential applications in both triggering and blocking allergic reactions.
    • The study provides a new tool for investigating IgE-mediated allergies and developing therapies.